Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease

BACKGROUND: SLE manifestations after ESRD may be underdiagnosed and undertreated, contributing to increased morbidity and mortality. Whether specific symptoms persist after ESRD or a shift towards new manifestations occurs has not been extensively studied, especially in the non-Caucasian patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgado Guerrero, Maria, Londono Jimenez, Alejandra, Dobrowolski, Chrisanna, Mowrey, Wenzhu B., Goilav, Beatrice, Wang, Shudan, Broder, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592532/
https://www.ncbi.nlm.nih.gov/pubmed/33115441
http://dx.doi.org/10.1186/s12882-020-02083-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592532/
https://www.ncbi.nlm.nih.gov/pubmed/33115441
http://dx.doi.org/10.1186/s12882-020-02083-2

Ejemplares similares